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SocietyLetter to the Editor
MRI-based semiquantitative assessment of subchondral bone marrow
lesions in osteoarthritis researchFig. 1. Image example comparing visualization of subchondral non-
cystic subchondral bone marrow lesion (BML) on fat-suppressed (FS)
intermediate-weighted (IW) fast spin echo (FSE) sequence and gradi-We would like to comment on magnetic resonance imaging
(MRI) assessment of bone marrow lesions (BMLs) in osteo-
arthritis (OA) research from a radiologic perspective. Selec-
tion of pulse sequences that are able to depict the
maximum extent of BMLs is of paramount importance for
subsequent correct assessment of the size of these lesions.
A recently published article investigating a canine OA
model by MRI suggested that to accurately assess semi-
quantitative size and extent of BMLs a combination of
different pulse sequences should be used, and that this in-
formation could also apply to human clinical studies1. In that
study the authors used a protocol of T1-weighted three-
dimensional (3D) fast gradient recalled echo (GRE), sagittal
fat-suppressed (FS) 3D spoiled gradient echo at a steady
state (SPGR), and sagittal T2-weighted fast spin echo
(FSE) with fat saturation sequences and assessed BMLs
using a semiquantitative scoring approach. Another article
by the same research group published in ‘‘Annals of the
Rheumatic Diseases’’ recently investigated subchondral
bone lesions with a quantitative MRI approach2. Acquisition
of BMLs in that publication was performed on a 1.5 T sys-
tem using a single 3D fast imaging with steady state preces-
sion (FISP) e sequence, a GRE-type sequence.
While it has been shown that GRE-type sequences such
as SPGR, fast low angle shot (FLASH), 3-point Dixon, dou-
ble echo steady state (DESS) and others are very sensitive
in delineating subchondral cysts, ‘‘even with robust FS or
WE [water excitation], these sequences are notoriously
insensitive to marrow abnormality’’3 due to trabecular mag-
netic susceptibility or T2* effects and will not show the true
extent of these lesions (Fig. 1). Inferior demonstration of sub-
chondral bone marrow changes on GRE-type sequences
has also been acknowledged by other radiological research
groups4,5. This fact was summarized and published in a con-
sensus statement by OMERACT (Outcome Measures in
Rheumatology Clinical Trials) and OARSI (Osteoarthritis
Research Society International) in 20063. For these reasons
research groups in the radiological community have been
applying either T2-weighted, proton density (PD)-weighted,
intermediate-weighted (IW) FS FSE or short tau inversion
recovery (STIR) sequences to assess non-cystic BMLs
in OA research6e10. It has also been suggested that compa-
rable results for BML assessment may be achieved for
T1-weighted FS sequences after intravenous gadoliniument recalled echo-type sequence on a 3.0 T MRI system. (A) Sagittal
IW FS FSE image. Large subchondral BML in medial tibia is depicted
(white arrows). Note also area of metaphyseal femoral red marrow
reconversion exhibiting a similar appearance as the subchondral BML
(black arrows). (B) Sagittal double echo steady state (DESS) image
shows neither the tibial BML nor the marrow reconversion. This is the
same knee and same slice position as in Fig. 1(A).
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to be proven in larger ongoing OA studies11,12.
For the above mentioned facts we wish to point out that
semiquantitative assessment of subchondral non-cystic ill-
deﬁned BMLs in conjunction with OA should not be
performed on GRE-type sequences as these will underesti-
mate size of the lesion. For semiquantitative estimation of
lesion size gradient echo-type sequences will not add infor-
mation to T2-, IW- or PD-weighted FS or STIR sequences.
However, assessment of BMLs is facilitated when two or
three orthogonal sequences of similar image characteristic
(i.e., T2-, IW-, PD-weighted FSE or STIR) are applied in or-
der to exactly locate the lesion and optimize size estimation.
GRE-type sequences are helpful to distinguish cystic from
non-cystic marrow lesions.
As a consequence of the above it is unclear what the re-
sults presented by this group pertaining to BMLs represent.
The size estimation will be inaccurate, so adequately inter-
preting the results and the resultant conclusions is not
possible. If the part of a BML that is depicted by certain
GRE-type sequences represents different histopathologic
changes as suggested by d’Anjou et al. remains to be proven
by future radiologic-pathologic correlation studies. We would
strongly encourage others to use appropriate MRI pulse
sequences to determine tissue-speciﬁc abnormalities, and
when there is uncertainty seek collaborative assistance
from adequately trained musculoskeletal radiologists.
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